title: Yeast growth selection system for the identification of cell-active inhibitors of beta-secretase.
abstract: Abeta peptides, which are believed to be at the origin of Alzheimer's disease (AD), are produced through the sequential processing of the transmembrane amyloid precursor protein (APP) by the beta- and gamma-secretase. The identification of small molecules that penetrate the brain and inhibit these secretases is of great therapeutic potential. Here, we describe a cellular selection system in yeast for the identification of inhibitors of the human beta-secretase BACE-1. Similar to the natural situation in mammalian cells, BACE-1 and its substrate APP are bound to membranes in secretory pathway compartments. Yeast cells expressing these human proteins have been engineered so as to grow under selective conditions only upon reduction of BACE-1 activity, thus allowing identification of compounds that, in addition to inhibiting BACE-1, must permeate cellular membranes and present no cytotoxic effects. Our results show that gradual reduction of BACE-1 expression in the engineered yeast strain resulted in gradual increase of cell growth rate. Moreover, two validated BACE-1 inhibitors, which have IC50 values between 7 and 8 microM in mammalian cell assays, stimulated yeast growth in a concentration-dependent manner. This effect was specific for BACE-1 since these compounds had no effect on yeast cells expressing a different secretase cleaving the APP substrate at the alpha-site. The target-specific cellular assay presented here is applicable in high-throughput screens for selecting inhibitors of defined secretases acting on natural substrates in a membrane-bound protein configuration.
authors.affiliation: ESBATech AG, Wagistrasse 21, CH-8952 Zürich-Schlieren, Switzerland.
authors.forename: Oliver
authors.initials: O
authors.lastname: Middendorp
authors.forename: Christopher
authors.initials: C
authors.lastname: Ortler
authors.forename: Ulf
authors.initials: U
authors.lastname: Neumann
authors.forename: Paolo
authors.initials: P
authors.lastname: Paganetti
authors.forename: Urs
authors.initials: U
authors.lastname: Lüthi
authors.forename: Alcide
authors.initials: A
authors.lastname: Barberis
mesh_terms: D053829:Amyloid Precursor Protein Secretases; D016282:Aspartic Acid Endopeptidases / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism*; D001681:Biological Assay; D002455:Cell Division / Q000502:physiology; D004318:Doxycycline / Q000494:pharmacology; D010450:Endopeptidases; D005786:Gene Expression Regulation; D006801:Humans; D011401:Promoter Regions, Genetic; D011480:Protease Inhibitors / Q000378:metabolism*; D014158:Transcription, Genetic; D015003:Yeasts / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*
chemical_list: D011480:Protease Inhibitors; D053829:Amyloid Precursor Protein Secretases; D010450:Endopeptidases; D016282:Aspartic Acid Endopeptidases; C509280:BACE1 protein, human; D004318:Doxycycline